Success Metrics

Active Trials
2(33%)

Phase Distribution

Ph phase_1
1
17%
Ph phase_4
4
67%
Ph not_applicable
1
17%

Phase Distribution

1

Early Stage

0

Mid Stage

4

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
1(16.7%)
Phase 4Post-market surveillance
4(66.7%)
N/ANon-phased studies
1(16.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

6

all time

Status Distribution
Active(4)
Other(2)

Detailed Status

unknown2
Enrolling by invitation1
Active, not recruiting1
Not yet recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
2
Success Rate
N/A
Most Advanced
Phase 4

Trials by Phase

Phase 11 (16.7%)
Phase 44 (66.7%)
N/A1 (16.7%)

Trials by Status

enrolling_by_invitation117%
active_not_recruiting117%
not_yet_recruiting117%
recruiting117%
unknown233%

Recent Activity

2 active trials
Showing 5 of 6
not_yet_recruitingphase_4

A Study to Evaluate the Effect of Recombinant Zoster Vaccine on New Diagnosis of Dementia in an Older Adult Population Aged 76 Years or Older in Finland

NCT07502560
enrolling_by_invitationphase_4

Recombinant Zoster Vaccine in Young Adult Solid Organ Transplant Recipients

NCT06162494
active_not_recruitingphase_4

Immune Response of Shingrix Vaccine in People Living With HIV (> 50 y.o.) Compared to Age-matched Controls

NCT05575830
recruitingphase_4

Immunogenicity of the Recombinant Zoster Vaccine in Multiple Sclerosis Patients

NCT05596526
unknownphase_1

Phase I Clinical Trial of a Candidate Herpes Zoster Vaccine

NCT05718037
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT07502560Phase 4

A Study to Evaluate the Effect of Recombinant Zoster Vaccine on New Diagnosis of Dementia in an Older Adult Population Aged 76 Years or Older in Finland

Not Yet Recruiting
NCT06162494Phase 4

Recombinant Zoster Vaccine in Young Adult Solid Organ Transplant Recipients

Enrolling By Invitation
NCT05575830Phase 4

Immune Response of Shingrix Vaccine in People Living With HIV (> 50 y.o.) Compared to Age-matched Controls

Active Not Recruiting
NCT05596526Phase 4

Immunogenicity of the Recombinant Zoster Vaccine in Multiple Sclerosis Patients

Recruiting
NCT05718037Phase 1

Phase I Clinical Trial of a Candidate Herpes Zoster Vaccine

Unknown
NCT04516408Not Applicable

Recombinant Zoster Vaccine in Stable SLE Patients

Unknown

All 6 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
6